Skip to content

Nedocromil

Mast Cell Stabilizer — RESPIRATORY SYSTEM

Also known as: nedocromil sodium

OfmFDA approvedATC R01AC07ATC R03BC03ATC S01GX04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Nedocromil is an ofm drug in the Mast Cell Stabilizer class catalogued in DrugCentral. It was first approved by the FDA in 1992. DrugCentral lists 2 molecular targets, including GPR35 and CYSLTR1. Recorded indications include Allergic conjunctivitis, Asthma, Asthma management and Ocular Itching.

  • Approval status: ofm (first approved 1992 by the FDA).
  • Drug class: Mast Cell Stabilizer.
  • Molecular targets: GPR35 and CYSLTR1 (2 listed in DrugCentral).
  • Indications: Allergic conjunctivitis, Asthma, Asthma management and Ocular Itching.
  • ATC code: R01AC07 (Antiallergic agents, excl. corticosteroids).
  • Molecular formula: C19H17NO7; molecular weight 371.35 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (4)

  • Allergic conjunctivitis
  • Asthma
  • Asthma management
  • Ocular Itching

Off-label uses (1)

  • Bronchospasm Prevention

Mechanism & targets

Established pharmacologic classMast Cell Stabilizer

Molecular targets (2)

TargetGeneActionActivity
G-protein coupled receptor 35GPR35agonistEC50 6.01
Cysteinyl leukotriene receptor 1CYSLTR1unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1992-12-30FDA—KING PHARMS

ATC classification

ATC codeTherapeutic hierarchy
R01AC07RESPIRATORY SYSTEM › NASAL PREPARATIONS › DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE › Antiallergic agents, excl. corticosteroids
R03BC03RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS › Antiallergic agents, excl. corticosteroids
S01GX04SENSORY ORGANS › OPHTHALMOLOGICALS › DECONGESTANTS AND ANTIALLERGICS › Other antiallergics

Chemical structure

Molecular formulaC19H17NO7
Molecular weight371.35 g/mol
CAS number69049-73-6
InChIKeyRQTOOFIXOKYGAN-UHFFFAOYSA-N
PubChem CID50294
CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Nedocromil used for?

DrugCentral lists the following indications for Nedocromil: Allergic conjunctivitis, Asthma, Asthma management and Ocular Itching.

How does Nedocromil work?

Its molecular targets in DrugCentral include GPR35 (agonist) and CYSLTR1.

When was Nedocromil first approved?

Nedocromil was first approved by the FDA in 1992.

What drug class does Nedocromil belong to?

Nedocromil is in the Mast Cell Stabilizer class.

What is the chemical formula of Nedocromil?

Nedocromil has the molecular formula C19H17NO7 and a molecular weight of 371.35 g/mol.

Browse: all drugs starting with N · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1992-12-30
AgencyFDA
Targets2
Indications4
FormulaC19H17NO7
DrugCentral ID1889
Interactive profile